Fidelity SPDR Advertisement
Home > Boards > Free Zone > All Trading - Technical > GoodFellas Big Board Catalyst and Chart Plays

GNOM - Research/DD summary & charts !

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
dDT  Member Profile
Member Level 
Followed By 479
Posts 72,453
Boards Moderated 4
Alias Born 03/31/08
160x600 placeholder
Couche-tard To Buy Pantry For $860 Million
Alimentation Couche-Tard agreed to buy convenience-store chain Pantry for about $860 million, strengthening its position in the southeastern U.S.
More Top Equities Stories Of The Day
Banks Find Niche Helping Firms Defend Against Activists
Repsol to Buy Talisman Energy for $8.3 Billion --Update
BofA Whistleblower to Get Nearly $58 Million--Filing
European Stocks Buffeted by Oil -- 3rd Update
OnDeck Capital Surges Above $20 IPO Price
ADR Shares End Lower; BT Group Shares Trade Actively
Hong Kong Pulls Into Second in IPOs
Chrysler Group Changes Name to Mirror Parent Fiat -- Update
dDT Member Level  Saturday, 01/07/12 08:05:22 AM
Re: dDT post# 1694
Post # of 81906 
GNOM - Research/DD summary & charts !

Complete Genomics, Inc., a life sciences company, develops and commercializes a DNA sequencing platform for human genome sequencing and analysis. Its Complete Genomics Analysis platform combines its proprietary human genome sequencing technology with informatics and data management software to provide customers with data that is ready to be used for genome-based research. The company's human genome sequencing services have applications in cancer research, Mendelian disease research, rare variant disease research, and clinical trial optimization. Its customers include academic and government research centers, and biopharmaceutical companies. The company was founded in 2005 and is headquartered in Mountain View, California.

Company's website: http://www.completegenomics.com/

Financial Reports: http://ir.completegenomics.com/financials.cfm

SEC filings: http://ir.completegenomics.com/sec.cfm

Nasdaq.com Stock Research - Analyst Summary

http://www.nasdaq.com/symbol/gnom/analyst-research


Contacts

Investor Relations Contact:
Scott Sandler
Director, Financial Planning & Analysis
Complete Genomics, Inc.
ssandler@completegenomics.com
650.943.2788

GNOM Chart


Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist